EUVIMEDEUVIMED entdecken
Crossref

Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Shaojuan Cui, Xiaoyan Tan, Jianchuan Deng, Qing Yang, Jia Yao, Nan Zhang, Yan Shen

Diseases and Research · 2023

DOI: 10.54457/dr.202301002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases and Research, 2023. Verfasst von Shaojuan Cui und 6 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cui, S., Tan, X., Deng, J., Yang, Q., Yao, J., Zhang, N., & Shen, Y. (2023). Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia. Diseases and Research. https://doi.org/10.54457/dr.202301002

Vancouver

Cui S, Tan X, Deng J, Yang Q, Yao J, Zhang N, et al. Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia. Diseases and Research. 2023. doi:10.54457/dr.202301002

BibTeX
@article{Cui2023,
  author = {Cui, Shaojuan and Tan, Xiaoyan and Deng, Jianchuan and Yang, Qing and Yao, Jia and Zhang, Nan and Shen, Yan},
  title = {Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia},
  journal = {Diseases and Research},
  year = {2023},
  doi = {10.54457/dr.202301002}
}
Kostenlos starten →